Search results
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 8 hours agoNovavax (NVAX 10.29%) stock has both soared and plummeted at times in recent years. Investors...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 5 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 2 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 4 hours agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
The Highest Paid CEOs of 2023
The Wall Street Journal· 2 days agoBottom of the pack Among the 25 worst-performing companies in the Journal analysis, nearly a third operated in the healthcare sector, including six...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 5 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via AOL· 5 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via Yahoo News· 5 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 5 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...